Reinventing Biotech’s Business Model: The Photo Gallery

4/4/12Follow @xconomy

(Page 13 of 24)

NEXT IMAGE >>
Reinventing Biotech’s Business Model— Cliff Stocks, the CEO of Theraclone Sciences (left) talked about incorporating some of the business lessons learned from two very different models at his past companies, Icos and Calistoga Pharmaceuticals. On the right is Alex Lash of Startup magazine, who moderated the second half of afternoon chats.
Photo by Luke Timmerman

Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 previous page
  • R. Jones

    When you talk about having enough former company T-shirts to build a quilt, you are really talking about enough soul crushing layoffs to kill ones desire to continue pursuing a career in this industry. We’re talking about a huge quilt that represents the loss of billions of dollars.

  • R. Jones

    Quip: a witty or funny observation or response usually made on the spur of the moment.

  • Pingback: Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? | Xconomy